Clinical Trial Update: CiLostAzol for pReventIon of Recurrent sTroke in Africa [Phase 3]

View source ↗

Summary

Phase 3 trial update for CiLostAzol to prevent recurrent stroke in Africa; study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: Northern California Institute of Research and Education | Conditions: Stroke | Phase 3 | Status: NOT_YET_RECRUITING